Overview

A Study of the Effect of SYN-010 on Subjects With IBS-C

Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multi-Dose Study of the Effect of Two Dosage Strengths of SYN-010 Compared with Placebo on Breath Methane Production in Breath Methane-Positive Subjects with Irritable Bowel Syndrome with Constipation (IBS-C)
Phase:
Phase 2
Details
Lead Sponsor:
Synthetic Biologics Inc.